{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:39:49Z","timestamp":1786372789124,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Despitethe multiple depicted associations of CKD with reduced cardiovascular and overall prognoses, the association of CKD with outcome of patients undergoing transcatheter aortic valve implantation has still not been well described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>Data from all hospitalized patients who underwent transcatheter aortic valve implantation procedures between January 1, 2010 and December 31, 2013 in Germany were evaluated regarding influence of CKD, even in the earlier stages, on morbidity, in-hospital outcomes, and costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 28,716 patients were treated with transcatheter aortic valve implantation. A total of 11,189 (39.0%) suffered from CKD. Patients with CKD were predominantly women; had higher rates of comorbidities, such as coronary artery disease, heart failure at New York Heart Association 3\/4, peripheral artery disease, and diabetes; and had a 1.3-fold higher estimated logistic European System for Cardiac Operative Risk Evaluation value. In-hospital mortality was independently associated with CKD stage \u22653 (up to odds ratio, 1.71; 95% confidence interval, 1.35 to 2.17;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.05), bleeding was independently associated with CKD stage \u22654 (up to odds ratio, 1.82; 95% confidence interval, 1.47 to 2.24;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001), and AKI was independently associated with CKD stages 3 (odds ratio, 1.83; 95% confidence interval, 1.62 to 2.06) and 4 (odds ratio, 2.33; 95% confidence interval, 1.92 to 2.83 both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). The stroke risk, in contrast, was lower for patients with CKD stages 4 (odds ratio, 0.23; 95% confidence interval, 0.16 to 0.33) and 5 (odds ratio, 0.24; 95% confidence interval, 0.15 to 0.39; both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Lengths of hospital stay were, on average, 1.2-fold longer, whereas reimbursements were, on average, only 1.03-fold higher in patients who suffered from CKD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This analysis illustrates for the first time on a nationwide basis the association of CKD with adverse outcomes in patients who underwent transcatheter aortic valve implantation. Thus, classification of CKD stages before transcatheter aortic valve implantation is important for appropriate risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.10471016","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T20:35:52Z","timestamp":1489437352000},"page":"718-726","source":"Crossref","is-referenced-by-count":20,"title":["Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation"],"prefix":"10.2215","volume":"12","author":[{"given":"Florian","family":"L\u00fcders","sequence":"first","affiliation":[{"name":"Division of Vascular Medicine, Department of Cardiovascular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology I, Heart Center, Freiburg University, Freiburg, Germany; and"},{"name":"Institute for Medical Biometry and Statistics, Medical Center, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Kaleschke","sequence":"additional","affiliation":[{"name":"Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Gebauer","sequence":"additional","affiliation":[{"name":"Division of Vascular Medicine, Department of Cardiovascular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Meyborg","sequence":"additional","affiliation":[{"name":"Division of Vascular Medicine, Department of Cardiovascular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser M.","family":"Malyar","sequence":"additional","affiliation":[{"name":"Division of Vascular Medicine, Department of Cardiovascular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Freisinger","sequence":"additional","affiliation":[{"name":"Division of Vascular Medicine, Department of Cardiovascular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Reinecke","sequence":"additional","affiliation":[{"name":"Division of Vascular Medicine, Department of Cardiovascular Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Rein\u00f6hl","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology I, Heart Center, Freiburg University, Freiburg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.athoracsur.2006.07.048","article-title":"Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis.","volume":"82","author":"Varadarajan","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B2-20230813","first-page":"230","article-title":"Guidelines on the management of valvular heart disease; The task force on the management of valvular heart disease of the European society of cardiology.","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"key":"B3-20230813","first-page":"e84","article-title":"ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"114","author":"Bonow","year":"2006","journal-title":"Circulation"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"PARTNER 2 Investigators: Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jcin.2015.01.009","article-title":"Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: The U.K. transcatheter aortic valve implantation registry.","volume":"8","author":"Duncan","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis.","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.109.907402","article-title":"Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN\u2122 valve.","volume":"122","author":"Thomas","year":"2010","journal-title":"Circulation"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1161\/CIRCULATIONAHA.108.837807","article-title":"Transcatheter aortic valve implantation: Impact on clinical and valve-related outcomes.","volume":"119","author":"Webb","year":"2009","journal-title":"Circulation"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jacc.2007.04.047","article-title":"Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome.","volume":"50","author":"Grube","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.amjcard.2004.11.025","article-title":"Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure.","volume":"95","author":"Varma","year":"2005","journal-title":"Am J Cardiol"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-7120-9-31","article-title":"Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease.","volume":"9","author":"Masuda","year":"2011","journal-title":"Cardiovasc Ultrasound"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.05600515","article-title":"CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia.","volume":"11","author":"L\u00fcders","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","article-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease.","volume":"42","author":"Drey","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/CIRCULATIONAHA.112.091371","article-title":"Long-term survival after aortic valve replacement among high-risk elderly patients in the United States.","volume":"126","author":"Brennan","year":"2012","journal-title":"Circulation"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.athoracsur.2011.02.015","article-title":"Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement.","volume":"91","author":"Thourani","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.athoracsur.2007.05.010","article-title":"High-risk aortic valve replacement: Are the outcomes as bad as predicted?","volume":"85","author":"Grossi","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jacc.2013.04.057","article-title":"Prognostic value of chronic kidney disease after transcatheter aortic valve implantation.","volume":"62","author":"Yamamoto","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/0003319716638797","article-title":"The impact of chronic kidney disease on hospitalized patients with peripheral arterial disease and critical limb ischemia","volume":"68","author":"L\u00fcders","year":"2017","journal-title":"Angiology"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: From subspecialty to global health burden.","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","article-title":"Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from kidney disease improving global outcomes.","volume":"72","author":"Levey","year":"2007","journal-title":"Kidney Int"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa1500893","article-title":"Effect of availability of transcatheter aortic-valve replacement on clinical practice.","volume":"373","author":"Rein\u00f6hl","year":"2015","journal-title":"N Engl J Med"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.","volume":"64","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jacc.2013.10.058","article-title":"Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: Insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).","volume":"63","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.jacc.2015.03.014","article-title":"Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial.","volume":"65","author":"Thyregod","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients.","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jcin.2012.12.128","article-title":"Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.","volume":"6","author":"Binder","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4244\/EIJV8I1A20","article-title":"Risk of stroke after transcatheter aortic valve implantation (TAVI): A meta-analysis of 10,037 published patients.","volume":"8","author":"Eggebrecht","year":"2012","journal-title":"EuroIntervention"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jama.2015.1474","article-title":"Clinical outcomes at 1 year following transcatheter aortic valve replacement.","volume":"313","author":"Holmes","year":"2015","journal-title":"JAMA"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ndt\/gfv009","article-title":"Chronic kidney disease and the risk of stroke: A systematic review and meta-analysis.","volume":"30","author":"Masson","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1161\/CIRCULATIONAHA.112.093096","article-title":"The placement of aortic transcatheter valve (PARTNER) trial: The surgeon\u2019s perspective: Celebration and concern.","volume":"125","author":"Guyton","year":"2012","journal-title":"Circulation"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2015.03.034","article-title":"Perioperative results and complications in 15,964 transcatheter aortic valve replacements: Prospective data from the GARY registry.","volume":"65","author":"Walther","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jcin.2011.03.019","article-title":"Transfemoral aortic valve implantation new criteria to predict vascular complications.","volume":"4","author":"Hayashida","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jacc.2009.12.014","article-title":"Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience.","volume":"55","author":"Rod\u00e9s-Cabau","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/ndt\/gfm879","article-title":"Impact of different stages of chronic kidney disease on in-hospital costs in patients with coronary heart disease.","volume":"23","author":"Meyer","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"B38-20230813","first-page":"312","article-title":"Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: A managed care perspective.","volume":"15","author":"Lalibert\u00e9","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","article-title":"Peripheral arterial disease and critical limb ischaemia: Still poor outcomes and lack of guideline adherence.","volume":"36","author":"Reinecke","year":"2015","journal-title":"Eur Heart J"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201705000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:36:38Z","timestamp":1786368998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201705000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.10471016","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}